Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

Abstract

This postmarketing safety assessment will provide important information regarding the safety of saxagliptin and could potentially identify important dipeptidyl peptidase-4 inhibitor class effects. The methods described may be useful to others planning similar evaluations.